Reacción dermatológica fatal después de infiximab

Roqué, Carmen; Lastra, Cintia; Onetti, Laura; Mussano, Eduardo; Dionisio de Cabalier, María Elisa.
Rev. argent. reumatol ; 24(1): 44-48, 2013. ilus
Artículo en Español | LILACS | ID: lil-696417

Documentos relacionados

  1. Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis.
  2. A protective ACPA.
  3. New molecular targets in the treatment of rheumatoid arthritis.
  4. Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: A prospective study.
  5. [The changing face of rheumatoid arthritis].
  6. Rheumatoid arthritis: thinking and understanding disease through a broader lens.
  7. PRIME Cells Predicting Rheumatoid Arthritis Flares. Reply.
  8. Polyarthrite rhumatoïde.
  9. Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study.
  10. Increased circulating sclerostin levels in rheumatoid arthritis patients: an updated meta-analysis.